Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of...
40 insider purchases on record · latest filing 2026-06-12.
Insiders have also filed 5 sale transactions at SMMT.